Related references
Note: Only part of the references are listed.Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors
M. W. Saif et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo
Yajun Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
A chemical proteomics approach reveals Hsp27 as a target for proapoptotic clerodane diterpenes
Laura Faiella et al.
MOLECULAR BIOSYSTEMS (2012)
Structural characterization of tetranortriterpenes from Pseudrocedrela kotschyi and Trichilia emetica and study of their activity towards the chaperone Hsp90
Fabrizio Dal Piaz et al.
PHYTOCHEMISTRY (2012)
Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90
Fabrizio Dal Piaz et al.
PLOS ONE (2012)
Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
R. E. Wang
CURRENT MEDICINAL CHEMISTRY (2011)
Metabolites of the Ellagitannin Geraniin and Their Antioxidant Activities
Hideyuki Ito
PLANTA MEDICA (2011)
Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges
Peter W. Piper et al.
PHARMACEUTICALS (2011)
The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition
Chiara Giommarelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
The Identification of a Novel Natural Activator of p300 Histone Acetyltranferase Provides New Insights into the Modulation Mechanism of this Enzyme
Fabrizio Dal Piaz et al.
CHEMBIOCHEM (2010)
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Shivaani Kummar et al.
EUROPEAN JOURNAL OF CANCER (2010)
Hsp90: A Drug Target?
Jeffrey M. Holzbeierlein et al.
CURRENT ONCOLOGY REPORTS (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
(-)-Epigallocatechin-3-gallate Is a Novel Hsp90 Inhibitor
Zhengyu Yin et al.
BIOCHEMISTRY (2009)
KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic Cells
Shary N. Shelton et al.
MOLECULAR PHARMACOLOGY (2009)
A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
Elisabeth I. Heath et al.
CLINICAL CANCER RESEARCH (2008)
Intra- and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90
Christian N. Cunningham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gedunin, a Novel Hsp90 inhibitor: Semisynthesis of Derivatives and Preliminary Structure-Activity Relationships
Gary E. L. Brandt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Tao Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Geraniin-mediated apoptosis by cleavage of focal adhesion kinase through up-regulation of Fas ligand expression in human melanoma cells
Jang-Chang Lee et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Structural basis for depletion of heat shock protein 90 client proteins by deguelin
Seung Hyun Oh et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Hsp90: A novel target for cancer therapy
David B. Solit et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Targeting multiple signal transduction pathways through inhibition of Hsp90
H Zhang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Label-free screening of bio-molecular interactions
MA Cooper
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2003)
Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery
WB Pratt et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Share Paper
